Influence of body weight on response to subcutaneous vitamin K administration in over-anticoagulated patients

Kevin C. Kelly, Guna Raj, Rick A. Weideman

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

PURPOSE: To determine the influence of body weight on the international normalized ratio (INR) response to a fixed dose of vitamin K in overanticoagulated patients. METHODS: Retrospective review of records of patients who received 1 mg of vitamin K subcutaneously to correct excessive INR. Dose of vitamin K in milligrams per kilograms plotted against change in INR in 24 hours. RESULTS: Fifteen patients were identified who met all inclusion criteria. Linear regression analysis plotted INR response at 24 hours versus dose of vitamin K adjusted for body weight. Pearson's product moment correlation (R = 0.85) indicated a significant relationship between INR response at 24 hours to an adjusted body weight dose of subcutaneous vitamin K (P = 0.0000523). A strong correlation (r = 0.69) also existed between INR response at 24 hours and the actual body weight dose of subcutaneous vitamin K (P = 0.004). CONCLUSIONS: In overanticoagulated patients, variability in response to vitamin K may be explained by variability in body weight. Dosing vitamin K according to body weight may result in a more predictable INR response.

Original languageEnglish (US)
Pages (from-to)623-627
Number of pages5
JournalAmerican Journal of Medicine
Volume110
Issue number8
DOIs
StatePublished - Jun 1 2001

Fingerprint

International Normalized Ratio
Vitamin K
Body Weight
Vitamin K 1
Linear Models
Regression Analysis

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Influence of body weight on response to subcutaneous vitamin K administration in over-anticoagulated patients. / Kelly, Kevin C.; Raj, Guna; Weideman, Rick A.

In: American Journal of Medicine, Vol. 110, No. 8, 01.06.2001, p. 623-627.

Research output: Contribution to journalArticle

@article{5d36591295064ad9bf0b71ed6f883e87,
title = "Influence of body weight on response to subcutaneous vitamin K administration in over-anticoagulated patients",
abstract = "PURPOSE: To determine the influence of body weight on the international normalized ratio (INR) response to a fixed dose of vitamin K in overanticoagulated patients. METHODS: Retrospective review of records of patients who received 1 mg of vitamin K subcutaneously to correct excessive INR. Dose of vitamin K in milligrams per kilograms plotted against change in INR in 24 hours. RESULTS: Fifteen patients were identified who met all inclusion criteria. Linear regression analysis plotted INR response at 24 hours versus dose of vitamin K adjusted for body weight. Pearson's product moment correlation (R = 0.85) indicated a significant relationship between INR response at 24 hours to an adjusted body weight dose of subcutaneous vitamin K (P = 0.0000523). A strong correlation (r = 0.69) also existed between INR response at 24 hours and the actual body weight dose of subcutaneous vitamin K (P = 0.004). CONCLUSIONS: In overanticoagulated patients, variability in response to vitamin K may be explained by variability in body weight. Dosing vitamin K according to body weight may result in a more predictable INR response.",
author = "Kelly, {Kevin C.} and Guna Raj and Weideman, {Rick A.}",
year = "2001",
month = "6",
day = "1",
doi = "10.1016/S0002-9343(01)00714-8",
language = "English (US)",
volume = "110",
pages = "623--627",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Influence of body weight on response to subcutaneous vitamin K administration in over-anticoagulated patients

AU - Kelly, Kevin C.

AU - Raj, Guna

AU - Weideman, Rick A.

PY - 2001/6/1

Y1 - 2001/6/1

N2 - PURPOSE: To determine the influence of body weight on the international normalized ratio (INR) response to a fixed dose of vitamin K in overanticoagulated patients. METHODS: Retrospective review of records of patients who received 1 mg of vitamin K subcutaneously to correct excessive INR. Dose of vitamin K in milligrams per kilograms plotted against change in INR in 24 hours. RESULTS: Fifteen patients were identified who met all inclusion criteria. Linear regression analysis plotted INR response at 24 hours versus dose of vitamin K adjusted for body weight. Pearson's product moment correlation (R = 0.85) indicated a significant relationship between INR response at 24 hours to an adjusted body weight dose of subcutaneous vitamin K (P = 0.0000523). A strong correlation (r = 0.69) also existed between INR response at 24 hours and the actual body weight dose of subcutaneous vitamin K (P = 0.004). CONCLUSIONS: In overanticoagulated patients, variability in response to vitamin K may be explained by variability in body weight. Dosing vitamin K according to body weight may result in a more predictable INR response.

AB - PURPOSE: To determine the influence of body weight on the international normalized ratio (INR) response to a fixed dose of vitamin K in overanticoagulated patients. METHODS: Retrospective review of records of patients who received 1 mg of vitamin K subcutaneously to correct excessive INR. Dose of vitamin K in milligrams per kilograms plotted against change in INR in 24 hours. RESULTS: Fifteen patients were identified who met all inclusion criteria. Linear regression analysis plotted INR response at 24 hours versus dose of vitamin K adjusted for body weight. Pearson's product moment correlation (R = 0.85) indicated a significant relationship between INR response at 24 hours to an adjusted body weight dose of subcutaneous vitamin K (P = 0.0000523). A strong correlation (r = 0.69) also existed between INR response at 24 hours and the actual body weight dose of subcutaneous vitamin K (P = 0.004). CONCLUSIONS: In overanticoagulated patients, variability in response to vitamin K may be explained by variability in body weight. Dosing vitamin K according to body weight may result in a more predictable INR response.

UR - http://www.scopus.com/inward/record.url?scp=0035368505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035368505&partnerID=8YFLogxK

U2 - 10.1016/S0002-9343(01)00714-8

DO - 10.1016/S0002-9343(01)00714-8

M3 - Article

C2 - 11382370

AN - SCOPUS:0035368505

VL - 110

SP - 623

EP - 627

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 8

ER -